Jyothy Labs Q2 FY27 Results Due After ₹773 Crore Q1 Sales

Jyothy Labs Limited is scheduled to report Q2 FY27 financial results on November 4, 2026, following Q1 revenue of ₹773 crore and profit after tax of ₹47.6 crore. The September-quarter disclosure will show whether the company has improved profitability after higher input costs affected margins in the June quarter.

When will Jyothy Labs announce its Q2 FY27 results?

Jyothy Labs is scheduled to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026, at its Board meeting on November 4. The company had indicated that it would report Q2 FY27 results at 9:15 AM IST, while its regulatory communication on the investor call did not specify a separate results-release time.

The company will hold an analyst and investor conference call at 4 PM IST on the same day. The call will cover the Q2 FY27 and first-half FY27 performance after the unaudited results are declared. Jyothy Labs made the conference-call announcement through a filing with the National Stock Exchange and BSE on October 14, 2026, in line with SEBI Regulation 30 requirements.

No Q2 FY27 revenue, profit, margin, or segment-level financial data was included in the conference-call announcement. Investors will therefore have to rely on the formal results filing and management commentary for the September-quarter numbers and the company’s operational observations.

How did Jyothy Labs perform in Q1 FY27?

Jyothy Labs reported revenue of ₹773 crore in Q1 FY27, up 3.0% year-on-year, while profit after tax declined 50.8% year-on-year to ₹47.6 crore. The June-quarter result reflected pressure from input costs, which reduced operating profitability despite growth in the company’s core businesses.

Operating EBITDA was ₹64.7 crore, translating to an EBITDA margin of 8.4%. The company’s reported Q1 revenue was 7.8% higher sequentially, but gross profit was 40.04% lower quarter-on-quarter and net profit declined 29.44% quarter-on-quarter, according to the provided quarterly data.

Core revenue, excluding Pril and Fa, increased 8.1% in value terms and 5.3% in volume terms during the quarter. Fabric Care recorded 14.1% value growth. Home Care grew 2.4% excluding Pril, indicating that performance varied across product categories.

Why are margins central to the Q2 FY27 update?

Margins are central because Jyothy Labs’ Q1 profit fell much faster than revenue growth, with profit after tax declining 50.8% year-on-year while revenue increased 3.0%. The company attributed the pressure to input costs, making its commentary on costs, pricing, and operating margins important in the Q2 disclosure.

The company sells consumer products through brands including Ujala, Pril, Margo and Exo. These categories can be affected by changes in raw-material costs, competitive promotions, pack-size changes, and consumer demand. Q1 core revenue growth showed that sales volumes and value growth remained positive in key operations, but the margin outcome was weaker.

The previous year’s September-quarter result also showed that volume growth did not necessarily translate into stronger profit. In Q2 FY26, Jyothy Labs reported revenue growth of 0.4% year-on-year to ₹736 crore and volume growth of 2.8%, while EBITDA declined 14.5% to ₹118.3 crore and net profit fell 16.3% to ₹87.8 crore.

Management had previously cited measures such as MRP reductions, higher grammage, and promotional price-offs, which created a gap between value and volume growth. It had also indicated an aim for double-digit volume growth for the full year in that period. The Q2 FY27 announcement will provide updated information on whether comparable commercial and cost factors remain relevant.

What does the Q2 update mean for investors and the FMCG sector?

For investors, the Q2 FY27 update will provide the first half-year view of Jyothy Labs’ revenue momentum and the extent of any recovery in profitability after the Q1 margin decline. No share-price movement, Q2 estimate, or company guidance for the September quarter was included in the supplied information, so the reported figures will be the basis for assessing the quarter.

Consensus estimates cited in the available updates show a mixed external view. The FY27 revenue forecast was raised to ₹3,250 crore from ₹3,180 crore, while the earnings-per-share estimate was reduced 14% to ₹8.98 from ₹10.48. These are analyst forecasts rather than company guidance and should be distinguished from formally reported financial results.

For the broader fast-moving consumer goods sector, the result is relevant because it combines volume trends in everyday household categories with the impact of input costs on margins. Jyothy Labs’ June-quarter data showed positive core revenue growth but lower profit, illustrating how revenue expansion alone may not determine earnings performance when costs increase.

The investor call may also give customers, distributors, and market participants information about demand conditions across Fabric Care, Home Care, Dishwashing, Personal Care, and Household Insecticides. Until the company releases the results, however, there is no disclosed Q2 FY27 financial outcome to assess.

Conclusion

Jyothy Labs enters its Q2 FY27 results day after reporting ₹773 crore revenue in Q1 and a 50.8% year-on-year fall in profit after tax to ₹47.6 crore. The central issue for the September quarter is whether sales and volume growth have translated into improved operating profitability amid the input-cost pressures identified in the June quarter.

Investors will next watch the unaudited Q2 and H1 FY27 results for revenue, EBITDA margin, profit, category performance, and any management observations on costs and demand. The analyst and investor call scheduled for 4 PM IST on November 4 is expected to discuss the formal quarterly disclosure and management’s outlook.